11-95191580-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144665.4(SESN3):c.166G>A(p.Asp56Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,612,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144665.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SESN3 | NM_144665.4 | c.166G>A | p.Asp56Asn | missense_variant | 3/10 | ENST00000536441.7 | NP_653266.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SESN3 | ENST00000536441.7 | c.166G>A | p.Asp56Asn | missense_variant | 3/10 | 2 | NM_144665.4 | ENSP00000441927 | P1 | |
LNCRNA-IUR | ENST00000657854.2 | n.508+33777C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151878Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250536Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135374
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460472Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726540
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151878Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74182
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.166G>A (p.D56N) alteration is located in exon 3 (coding exon 3) of the SESN3 gene. This alteration results from a G to A substitution at nucleotide position 166, causing the aspartic acid (D) at amino acid position 56 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at